Cargando…

The Prevalence, Progress and Risk Factor Control of Chronic Kidney Disease in Chinese Adults With Type 2 Diabetes Mellitus in Primary Care

OBJECTIVE: This study aimed to evaluate the prevalence of chronic kidney disease (CKD) in Chinese adults with T2DM in primary care, and the association of HbA(1c), blood pressure (BP) and triglycerides (TG), i.e. ABC control at follow up (FU) with the progress and regression of CKD. METHODS: A total...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Lingwang, Yu, Qiuzhi, Tang, Hong, Li, Xianglan, Wang, Dandan, Tang, Qi, Xing, Haiyang, He, Yali, Zhao, Xiaona, Zhao, Shuhui, Lee, Yaujiunn, Lu, Juming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226338/
https://www.ncbi.nlm.nih.gov/pubmed/35757423
http://dx.doi.org/10.3389/fendo.2022.859266
_version_ 1784733846992846848
author An, Lingwang
Yu, Qiuzhi
Tang, Hong
Li, Xianglan
Wang, Dandan
Tang, Qi
Xing, Haiyang
He, Yali
Zhao, Xiaona
Zhao, Shuhui
Lee, Yaujiunn
Lu, Juming
author_facet An, Lingwang
Yu, Qiuzhi
Tang, Hong
Li, Xianglan
Wang, Dandan
Tang, Qi
Xing, Haiyang
He, Yali
Zhao, Xiaona
Zhao, Shuhui
Lee, Yaujiunn
Lu, Juming
author_sort An, Lingwang
collection PubMed
description OBJECTIVE: This study aimed to evaluate the prevalence of chronic kidney disease (CKD) in Chinese adults with T2DM in primary care, and the association of HbA(1c), blood pressure (BP) and triglycerides (TG), i.e. ABC control at follow up (FU) with the progress and regression of CKD. METHODS: A total of 5123 patients with ≥3 measurements of estimated glomerular filtration rate (eGFR), urinary albumin-to-creatinine ratio (UACR), HbA(1c), BP, LDL-C and TG, and FU ≥ 12 months were included into final analysis. The presence of CKD was defined as the presence of albuminuria (UACR ≥ 30 mg/g), impaired eGFR (eGFR < 60 ml/min/1.73 m(2)) or both, and was categorised as low, moderate and high/very high risk. The change of CKD risk for outcome was categorised as stable (no change), progress (risk increase) and regress (risk decrease) from baseline to the last visits (LV). RESULTS: The prevalence of CKD, impaired eGFR and albuminuria was 29.6%, 5.8% and 27.1% at baseline, with 70.4%, 20.3%, 7.0% and 2.3% of patients distributed in low, moderate, high and very high risk group. There were 3457 (67.5%), 1120 (21.8%) and 546 (10.7%) patients had CKD outcome risk stable, progressed and regressed respectively. The proportion of patients reaching targets of BP ≤ 130/80 mmHg, HbA(1c)<7.5%, LDL-C<2.60 mmol/L increased from baseline to FU and LV, together with increased usage of insulin, RAS inhibitors and lipid lowering medications. After multivariable adjustment, the HbA(1c)<7.5% (OR: 0.66, 95%CI 0.56-0.78), TG< 1.7 mmol/L (OR: 0.81, 95%CI 0.68-0.96) at FU and BP ≤ 130/80 mmHg at LV (OR: 0.82, 95%CI 0.70-0.95) was negatively associated with CKD outcome risk progress. CONCLUSION: The prevalence of CKD was high with 21.8% of patients progressing to higher CKD outcome risk at FU, attention should be paid on long term and better ABC control.
format Online
Article
Text
id pubmed-9226338
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92263382022-06-25 The Prevalence, Progress and Risk Factor Control of Chronic Kidney Disease in Chinese Adults With Type 2 Diabetes Mellitus in Primary Care An, Lingwang Yu, Qiuzhi Tang, Hong Li, Xianglan Wang, Dandan Tang, Qi Xing, Haiyang He, Yali Zhao, Xiaona Zhao, Shuhui Lee, Yaujiunn Lu, Juming Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: This study aimed to evaluate the prevalence of chronic kidney disease (CKD) in Chinese adults with T2DM in primary care, and the association of HbA(1c), blood pressure (BP) and triglycerides (TG), i.e. ABC control at follow up (FU) with the progress and regression of CKD. METHODS: A total of 5123 patients with ≥3 measurements of estimated glomerular filtration rate (eGFR), urinary albumin-to-creatinine ratio (UACR), HbA(1c), BP, LDL-C and TG, and FU ≥ 12 months were included into final analysis. The presence of CKD was defined as the presence of albuminuria (UACR ≥ 30 mg/g), impaired eGFR (eGFR < 60 ml/min/1.73 m(2)) or both, and was categorised as low, moderate and high/very high risk. The change of CKD risk for outcome was categorised as stable (no change), progress (risk increase) and regress (risk decrease) from baseline to the last visits (LV). RESULTS: The prevalence of CKD, impaired eGFR and albuminuria was 29.6%, 5.8% and 27.1% at baseline, with 70.4%, 20.3%, 7.0% and 2.3% of patients distributed in low, moderate, high and very high risk group. There were 3457 (67.5%), 1120 (21.8%) and 546 (10.7%) patients had CKD outcome risk stable, progressed and regressed respectively. The proportion of patients reaching targets of BP ≤ 130/80 mmHg, HbA(1c)<7.5%, LDL-C<2.60 mmol/L increased from baseline to FU and LV, together with increased usage of insulin, RAS inhibitors and lipid lowering medications. After multivariable adjustment, the HbA(1c)<7.5% (OR: 0.66, 95%CI 0.56-0.78), TG< 1.7 mmol/L (OR: 0.81, 95%CI 0.68-0.96) at FU and BP ≤ 130/80 mmHg at LV (OR: 0.82, 95%CI 0.70-0.95) was negatively associated with CKD outcome risk progress. CONCLUSION: The prevalence of CKD was high with 21.8% of patients progressing to higher CKD outcome risk at FU, attention should be paid on long term and better ABC control. Frontiers Media S.A. 2022-06-10 /pmc/articles/PMC9226338/ /pubmed/35757423 http://dx.doi.org/10.3389/fendo.2022.859266 Text en Copyright © 2022 An, Yu, Tang, Li, Wang, Tang, Xing, He, Zhao, Zhao, Lee and Lu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
An, Lingwang
Yu, Qiuzhi
Tang, Hong
Li, Xianglan
Wang, Dandan
Tang, Qi
Xing, Haiyang
He, Yali
Zhao, Xiaona
Zhao, Shuhui
Lee, Yaujiunn
Lu, Juming
The Prevalence, Progress and Risk Factor Control of Chronic Kidney Disease in Chinese Adults With Type 2 Diabetes Mellitus in Primary Care
title The Prevalence, Progress and Risk Factor Control of Chronic Kidney Disease in Chinese Adults With Type 2 Diabetes Mellitus in Primary Care
title_full The Prevalence, Progress and Risk Factor Control of Chronic Kidney Disease in Chinese Adults With Type 2 Diabetes Mellitus in Primary Care
title_fullStr The Prevalence, Progress and Risk Factor Control of Chronic Kidney Disease in Chinese Adults With Type 2 Diabetes Mellitus in Primary Care
title_full_unstemmed The Prevalence, Progress and Risk Factor Control of Chronic Kidney Disease in Chinese Adults With Type 2 Diabetes Mellitus in Primary Care
title_short The Prevalence, Progress and Risk Factor Control of Chronic Kidney Disease in Chinese Adults With Type 2 Diabetes Mellitus in Primary Care
title_sort prevalence, progress and risk factor control of chronic kidney disease in chinese adults with type 2 diabetes mellitus in primary care
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226338/
https://www.ncbi.nlm.nih.gov/pubmed/35757423
http://dx.doi.org/10.3389/fendo.2022.859266
work_keys_str_mv AT anlingwang theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT yuqiuzhi theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT tanghong theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT lixianglan theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT wangdandan theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT tangqi theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT xinghaiyang theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT heyali theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT zhaoxiaona theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT zhaoshuhui theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT leeyaujiunn theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT lujuming theprevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT anlingwang prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT yuqiuzhi prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT tanghong prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT lixianglan prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT wangdandan prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT tangqi prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT xinghaiyang prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT heyali prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT zhaoxiaona prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT zhaoshuhui prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT leeyaujiunn prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare
AT lujuming prevalenceprogressandriskfactorcontrolofchronickidneydiseaseinchineseadultswithtype2diabetesmellitusinprimarycare